Philippos Patsalis interviewed about PreSENTIA

NBRI President and NIPD Genetics Founder and Chief Executive Officer, Philippos Patsalis has given an interview to philenews.com discussing about PreSENTIA a new generation test for identifying genetic mutations with cancer susceptibility.

Among other, Dr Patsalis explains that PreSENTIA has an extensive portfolio of 19 hereditary cancer panels. Each panel focuses on a specific set of genes that have high susceptibility to cancer predisposing syndromes, that in turn have increased risk of causing cancer.

Read the full interview here.